0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Product Request Form

Sipuleucel-T is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Sipuleucel-T becomes available, please fill out the form below.

Name:
Email:

*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Sipuleucel-T:

  • Antigua and Barbuda
  • Armenia
  • Bahamas
  • Belgium
  • Belize
  • Bolivia
  • Bulgaria
  • Cook Islands
  • Costa Rica
  • Denmark
  • European Union
  • Georgia
  • Germany
  • Gibraltar
  • Greenland
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Italy
  • Japan
  • Liechtenstein
  • Lithuania
  • Netherlands
  • Netherlands Antilles
  • Poland
  • Qatar
  • Romania
  • Russian Federation
  • Seychelles
  • Slovenia
  • Taiwan
  • Thailand
  • Tonga
  • Trinidad and Tobago
  • Ukraine
  • United Kingdom, UK
  • United States, US
  • Vietnam
View All Countries

Latest news releases on Sipuleucel-T:

Sipuleucel-T — Wikipédia

Le sipuleucel-T (connu aussi sous son nom commercial : Provenge) est le premier vaccin thérapeutique pour le traitement du cancer de la prostate au stade ...

Advanced Prostate Cancer Treatment | Provenge(sipuleucel - T)

PROVENGE ® (sipuleucel-T) is a prescription medicine that is used to treat certain patients with advanced prostate cancer. PROVENGE is made from your own immune cells.

Sipuleucel-T Immunotherapy for Castration-Resistant ...

Background Sipuleucel-T, an autologous active cellular immunotherapy, has shown evidence of efficacy in reducing the risk of death among men with metastatic ...

Sipuleucel-T - an overview | ScienceDirect Topics

Sipuleucel-T. Sipuleucel-T is an autologous dendritic cell vaccine that is produced by exposure and activation of the patient’s peripheral blood mononuclear cells ...

Sipuleucel-T | Hardoctor 2007 | il Blog di Carlo Cottone

Si chiama Provenge (Sipuleucel-T, Dendreon), ed è il primo vaccino terapeutico approvato dalla Food and Drug Administration contro il cancro, un’immunoterapia ...

Vaccine therapy with sipuleucel-T (Provenge) for prostate ...

Given the promising results of Phases I and II studies, a randomized Phase III clinical trial of sipuleucel-T (D9901) was undertaken in 1999. A total of 127 patients ...

PROVENGE (sipuleucel-T) - U S Food and Drug Administration ...

Questions and Answers - Provenge; FDA Online Label Repository Search this database for drug labeling and other information. The content has not been altered or ...

Advanced Prostate Cancer Terms | PROVENGE (sipuleucel-T)

Glossary. Apheresis: Withdrawal of blood from a person's body, removal of one or more components (such as plasma, platelets, or white blood cells), and transfusion of ...

Dendreon > Home Page

Opportunity. As a company, we plan to focus on our priorities of expanding access to PROVENGE ® (sipuleucel-T), both in the United States and around the world ...

NCCN Clinical Practice Guidelines in Oncology (NCCN ...

Clinical Trials: NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged.

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2018 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK